KSX01-TCRT Injection Project in Solid Tumors

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

March 7, 2023

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2028

Conditions
TCR-T CellsRefractory Solid TumorsRelapsed Solid Tumors
Interventions
DRUG

KSX01-TCRT injection

individualization TCR-T cell injection

Trial Locations (1)

530000

RECRUITING

The first affiliated hospital of Guang Xi medical university, Nanning

All Listed Sponsors
lead

TCRx Therapeutics Co.Ltd

INDUSTRY